Clinical proteomic analysis across the Alzheimer’s disease continuum
Sophia Weiner(Institute of Neurobiology), Johan Gobom(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Andréa Lessa Benedet(McGill University), Mathias Sauer(Sahlgrenska University Hospital), Henrik Zetterberg(Queen Mary University of London), Pedro Rosa‐Neto(Montreal Neurological Institute and Hospital), Nicholas J. Ashton(Alzheimer's Association)
Cited by 1
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
|The Lancet Neurology|2020|1.3k
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773